Artelo Biosciences Ownership | Who Owns Artelo Biosciences?
Artelo Biosciences Ownership Summary
Artelo Biosciences is owned by 6.17% institutional investors, 4.31% insiders, and 89.52% retail investors. Kathmere capital management is the largest institutional shareholder, holding 0% of ARTL shares. Fidelity Extended Market Index is the top mutual fund, with 0.47% of its assets in Artelo Biosciences shares.
ARTL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Artelo Biosciences | 6.17% | 4.31% | 89.52% |
| Sector | Healthcare Stocks | 50.50% | 12.33% | 37.17% |
| Industry | Biotech Stocks | 49.09% | 12.06% | 38.85% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Kathmere capital management | - | - | - |
| Advisor group | - | - | - |
| Citigroup | - | - | - |
| Clear street group | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Kathmere capital management | - | - | - |
| Advisor group | - | - | - |
| Citigroup | - | - | - |
| Clear street group | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Advisor group | - | - | -1.00 |
| Clear street group | - | - | -100.00 |
| Citigroup | - | - | -3.08K |
| Kathmere capital management | - | - | -13.25K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Kathmere capital management | - | - | -13.25K |
| Citigroup | - | - | -3.08K |
| Clear street group | - | - | -100.00 |
| Advisor group | - | - | -1.00 |
Sold Out
| Holder | Change |
|---|---|
| Advisor group | -1.00 |
| Clear street group | -100.00 |
| Citigroup | -3.08K |
| Kathmere capital management | -13.25K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 10 | - | 45,603 | - | 6 | - | 10 | - | - | - |
| Jun 30, 2022 | 11 | -26.67% | 1,383,628 | -5.65% | 3 | 27.12% | 5 | -44.44% | 2 | -50.00% |
| Mar 31, 2022 | 15 | -6.25% | 1,466,422 | -21.68% | 3 | 9.16% | 9 | 12.50% | 4 | - |
| Dec 31, 2021 | 16 | 14.29% | 1,872,284 | -5.76% | 6 | 5.44% | 8 | 14.29% | 4 | -20.00% |
| Sep 30, 2021 | 14 | -12.50% | 1,986,685 | -28.32% | 10 | 7.40% | 7 | -22.22% | 5 | 25.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Extended Market Index | 13.29K | 0.47% | 6.92K |
| Vanguard Institutional Extnd Mkt Idx Tr | 10.13K | 0.29% | - |
| NT Ext Equity Mkt Idx Fd - NL | 186.00 | 0.02% | -370.00 |
| SSgA U.S. Extended Market Index Class I | 693.00 | 0.02% | - |
| Spartan Extended Market Index Pool F | 500.00 | 0.01% | - |
| NT Ext Eq Mkt Indx Fd DC Lend T3 | 437.00 | 0.01% | 437.00 |
| NT Ext Eq Mkt Indx Fd DC Lend T4 | 437.00 | 0.01% | 437.00 |
| NT Ext Equity Mkt Idx Fd - L | 102.00 | 0.01% | -204.00 |
| Spartan Total Market Index Pool A1 | 340.00 | 0.01% | - |
| Spartan Total Market Index Pool G | 340.00 | 0.01% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 01, 2025 | FAVORITO TAMARA A | - | Buy | - |
| May 01, 2025 | MATSUI CONNIE | - | Buy | - |
| May 01, 2025 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | Buy | - |
| Aug 12, 2022 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | Buy | $4.80K |
| Aug 11, 2022 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | Buy | $4.84K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q1 | - | - |
| 2023 Q3 | - | - |
| 2023 Q2 | - | - |
| 2023 Q1 | - | - |
| 2022 Q3 | 2 | - |
ARTL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools